Flaggler County Sheriff Rick Staley's deputies arrested Autumn Bardisa Tuesday. The 29-year-old Palm Coast woman is charged with seven counts of practicing a healthc care profession without a license and seven counts of fraudulent use of personal identification information. Court documents say Bisa lied that she passed her exam.During the Advent Health hiring process, she also provided the license number matching another person with her first name and a different last name. Investigators obtained a list sho ...

Unitedhealth and home health and hospice care company Amedisys have reached a proposed a settlement with the US Justice Department in a lawsuit that challenged the companies’ $3.3 billion deal https://t.co/Dz04v51xeF ...

Company Overview - Fujifilm Holdings Corporation is based in Tokyo and utilizes its expertise in photographic film technology to explore opportunities in Healthcare, Electronics, and Imaging markets, with a diversified business model that includes imaging, healthcare, and high-performance materials [12] - The company reported revenues of ¥2,960.9 billion for fiscal 2023, reflecting a year-over-year increase of 3.6% [12] Financial Performance - Fujifilm has undergone a reorganization of its operating segments, now reporting results under four divisions: Healthcare, Electronics, Business Innovation, and Imaging [12] - The Zacks Consensus Estimate for Fujifilm's earnings has increased by $0.02 to $0.73 per share for fiscal 2026, with two analysts revising their earnings estimates upwards in the last 60 days [13] - The company has an average earnings surprise of +5.7%, indicating a positive trend in earnings performance [13] Investment Ratings - Fujifilm is currently rated as 3 (Hold) on the Zacks Rank, with a VGM Score of B, suggesting a solid investment potential [13][14] - The company also holds a Value Style Score of B, supported by attractive valuation metrics such as a forward P/E ratio of 15.18, which may appeal to value investors [13]

Physician Starting Pay Hits $400,000 A Year https://t.co/DnSSH4mGGX https://t.co/XMZVgZlVIZ ...

Financial Performance Highlights - Swire Pacific's underlying profit decreased by 2% to HK$5476 million in 1H2025, compared to HK$5576 million in 1H2024 [24, 34] - Recurring underlying profit decreased slightly by 1% to HK$4712 million in 1H2025 from HK$4762 million in 1H2024 [24, 34] - Ordinary dividend per 'A' share increased by 4% to HK$130 [24, 31, 34] - Revenue increased by 16% to HK$45774 million in 1H2025 from HK$39563 million in 1H2024 [34] Business Segment Performance - Property division's underlying profit increased by 15% to HK$4406 million [56] - Beverages division's attributable profit decreased by 9% to HK$803 million [89] - Aviation division (Cathay group) attributable profit increased by 1% to HK$1642 million [38, 98] - HAECO group recurring profit increased significantly by 40% to HK$561 million [30, 98, 118] Property Investment and Development - 67% committed in HK$100 billion investment plan [22, 58] - Completed the sale of interests in Brickell City Centre retail and parking spaces, as well as the adjacent sites, in Miami, USA [22] - Chinese Mainland portfolio contributed 42% attributable gross rental income in 1H2025 [71, 73] Beverages - Swire Coca-Cola - Revenue increased by 25% to HK$22188 million [89] - EBITDA margin remained almost flat at 128% [89, 91] - Inaugurated a new US$136 million flagship plant in Tay Ninh, Vietnam [78] Aviation - Cathay Pacific and HAECO - Cathay group reported a group profit of HK$43 billion [101] - HAECO group achieved a 40% growth in recurring profit [30, 98, 118]

Core Viewpoint - NextPlat Corp is set to release its financial results for the quarter ended June 30, 2025, on August 14, 2025, before market open, and will host a conference call to discuss these results and recent developments [1][2]. Group 1: Financial Results Announcement - NextPlat Corp will announce its financial results for Q2 2025 on August 14, 2025, before the market opens [1]. - The conference call will be hosted by Interim CEO David Phipps and CFO Cecile Munnik at 8:30 a.m. EDT [2]. Group 2: Conference Call Details - Investors can submit questions for the Q&A portion of the call before August 12, 2025 [2]. - The call can be accessed via a toll-free number (1-800-836-8184) or an international number (1-646-357-8785) [2]. - A live broadcast and replay of the conference call will be available on the company's website [3]. Group 3: Company Overview - NextPlat is a global consumer products and services company that provides healthcare and technology solutions through eCommerce and retail channels [4]. - The company aims to assist businesses in optimizing their eCommerce presence and revenue through acquisitions, joint ventures, and collaborations [4]. - NextPlat operates an eCommerce communications division and offers pharmacy and healthcare data management services in the U.S. through its subsidiary, Progressive Care [4].

Physician Starting Pay Hits $400,000 A Year https://t.co/UpMlwgtaxb https://t.co/t1K2fIfxl4 ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Hims & Hers Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the lawsuit is from April 29, 2025, to June 23, 2025, and the lead plaintiff deadline is August 25, 2025 [1]. - Investors who purchased Hims common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time and has recovered hundreds of millions of dollars for investors [3]. Group 3: Case Allegations - The lawsuit alleges that Hims made false and misleading statements regarding its partnership with Novo Nordisk A/S, which affected investors' decisions [4]. - Specific claims include the failure to disclose the nature of the collaboration with Novo and the implications for Hims subscribers' access to the weight-loss drug Wegovy [4].

Physician Starting Pay Hits $400,000 A Year https://t.co/0E1WCzh3bW https://t.co/jMWEgJZNvm ...

Financial Data and Key Metrics Changes - Second quarter sales reached $3.3 billion, growing 2% on an organic basis [6][15] - Operating EBITDA was $859 million, an increase of 8% year over year, resulting in an operating EBITDA margin of 26.4%, up 120 basis points from the prior year [6][17] - Adjusted EPS for the quarter was $1.12, up 15% year over year [6][19] Business Line Data and Key Metrics Changes - Electronics Co. net sales were $1.2 billion, up 6% year over year, driven by an 8% increase in volume [20] - Industrials Co. second quarter net sales were $2.1 billion, up 1% year over year, with 2% volume growth partially offset by a 1% decline in price [21][22] - Healthcare and Water Technologies saw high single-digit organic sales growth, while diversified industrial sales were down low single digits due to construction market softness [22][46] Market Data and Key Metrics Changes - Asia Pacific delivered 4% organic sales growth year over year, with Europe up 2% and North America up 1% [16] - The electronics market remains mixed, with growth primarily driven by AI applications, while consumer markets are still relatively weak [56][57] Company Strategy and Development Direction - The company is focused on the upcoming spin-off of Qunity Electronics, scheduled for November 1, aiming to position both entities for growth [8][10] - The new DuPont will emphasize high-growth healthcare and water markets, with plans for potential acquisitions to bolster these segments [12][71] - The company is committed to maintaining a strong cash flow and operational efficiency while navigating the separation process [8][24] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about continued strength in electronics driven by AI technology demand, while acknowledging ongoing weakness in the construction sector [7][24] - The company raised its full-year earnings guidance based on strong second-quarter performance, despite anticipated tariff impacts [23][24] - Management highlighted the importance of customer relationships and market positioning in driving future growth [71] Other Important Information - A settlement with the State of New Jersey regarding environmental claims was announced, with the company's portion amounting to $177 million on an NPV basis [8][41] - The company is actively pursuing M&A opportunities to enhance its healthcare and water portfolios [72] Q&A Session Summary Question: Insights on industrials and pricing impacts - Management clarified that the 1% price decline was primarily due to price adjustments following inflationary pressures, not specific to the healthcare or tieback sectors [30][31] Question: Comments on the recent settlement - Management expressed satisfaction with the settlement, noting that AFFF claims represented only 1% of the total settlement amount, aligning with previous estimates [39][41] Question: Growth in healthcare and water sectors - Both healthcare and water sectors experienced high single-digit growth, with expectations for continued outsized growth in the back half of the year [46][47] Question: Electronics market trends - Management noted that growth is primarily driven by AI applications, with expectations for gradual recovery in the broader electronics market [56][57] Question: Future M&A strategies - The focus remains on completing the spin-off of Qunity, while actively scouting for M&A opportunities in the healthcare and water sectors [72][73] Question: Tariff impacts and mitigation strategies - Over 90% of the tariff impact mitigation is attributed to supply chain movements, with some surcharges implemented to offset costs [132][133]